Assistant Professor
Department of Medical Sciences

Dr. Titunick teaches gross anatomy, histology, and embryology at the Hackensack Meridian School of Medicine.  Her research focuses on fracture repair in diabetes with a special interest in cell proliferation, vascularization, and mechanical strength.  Dr. Titunick is also heavily involved in the IHS IPE Research Seminar Series.

Education

• Ph.D., The Pennsylvania State University College of Medicine
• B.A., Rutgers University

Accomplishments

• Titunick MB, Lewis GS, Cain JD, Zagon IS, McLaughlin PJ. “Blockade of the OGF-OGFr pathway in diabetic bone.” Connect Tissue Res. 2019 Nov;60(6):521-529. PubMed PMID: 30931654.
• McLaughlin PJ, Sassani JW, Titunick MB, Zagon IS. “Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes.” BMC Ophthalmol. 2019 Jan 28;19(1):35. PubMed PMID: 30691415; PubMed Central PMCID: PMC6348650.
• McLaughlin PJ, Cain JD, Titunick MB, Sassani JW, Zagon IS. “Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds.” Adv Wound Care (New Rochelle). 2017 Sep 1;6(9):279-288. PubMed PMID: 28894635; PubMed Central PMCID: PMC5592845.
• Stockdale DP, Titunick MB, Biegler JM, Reed JL, Hartung AM, Wiemer DF, McLaughlin PJ, Neighbors JD. “Selective opioid growth factor receptor antagonists based on a stilbene isostere.” Bioorg Med Chem. 2017 Aug 15;25(16):4464-4474. PubMed PMID: 28693915; PubMed Central PMCID: PMC5567982.